Antithrombin-lowering in hemophilia: a closer look at fitusiran
Por um escritor misterioso
Descrição
IJMS, Free Full-Text
International consensus recommendations on the management of people with haemophilia B - Daniel P. Hart, Davide Matino, Jan Astermark, Gerard Dolan, Roseline d'Oiron, Cédric Hermans, Victor Jiménez-Yuste, Adriana Linares, Tadashi Matsushita, Simon
Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort - Pasi - 2021 - Journal of Thrombosis and Haemostasis - Wiley Online Library
A Molecular Revolution in the Treatment of Hemophilia. - Abstract - Europe PMC
Fitusiran, C78H139N11O30
RNAi for the treatment of people with hemophilia
Injectable drug may reduce bleeding in patients with hemophilia
Antithrombin-lowering in hemophilia: a closer look at fitusiran - Research and Practice in Thrombosis and Haemostasis
Antithrombin-lowering in hemophilia: a closer look at fitusiran - ScienceDirect
Hemophilia A (Factor VIII Deficiency): Practice Essentials, Background, Pathophysiology
Positive Phase III results for fitusiran in hemophilia
Fitusiran: A Game-Changing Drug for Hemophilia Patients
de
por adulto (o preço varia de acordo com o tamanho do grupo)
/pic7248997.jpg)
